Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 12, 2012
Promoter methylation confers kidney-specific expression of the Klotho geneMasahiro Azuma, Daisuke Koyama, Jiro Kikuchi, et al.
Oncotarget|February 22, 2018
Lysine-specific demethylase 1 inhibitors prevent teratoma development from human induced pluripotent stem cellsNaoki Osada, Jiro Kikuchi, Takashi Umehara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2018
Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 InhibitorShiori Saito, Jiro Kikuchi, Daisuke Koyama, et al.
Haematologica|August 18, 2025
FOXM1 down-regulation is a trigger of isatuximab-induced direct cell death in multiple myeloma cells with 1qJiro Kikuchi, Naoki Osada, Sae Matsuoka, et al.
Blood|March 31, 2010
Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myelomaJiro Kikuchi, Taeko Wada, Rumi Shimizu, et al.
Leukemia|July 31, 2019
Soluble SLAMF7 promotes the growth of myeloma cells via homophilic interaction with surface SLAMF7Jiro Kikuchi, Mitsuo Hori, Hidekatsu Iha, et al.
Circulation Research|March 29, 2003
Defective sorting to secretory vesicles in trans-Golgi network is partly responsible for protein C deficiency: molecular mechanisms of impaired secretion of abnormal protein C R169W, R352W, and G376DMasao Naito, Jun Mimuro, Hitoshi Endo, et al.
Cancer Research|February 5, 2008
CD43, but not P-selectin glycoprotein ligand-1, functions as an E-selectin counter-receptor in human pre-B-cell leukemia NALL-1Chizu Nonomura, Jiro Kikuchi, Nobutaka Kiyokawa, et al.
Plos One|March 15, 2014
Purine analog-like properties of bendamustine underlie rapid activation of DNA damage response and synergistic effects with pyrimidine analogues in lymphoid malignanciesNobuya Hiraoka, Jiro Kikuchi, Takahiro Yamauchi, et al.
Plos One|April 18, 2013
Homopiperazine derivatives as a novel class of proteasome inhibitors with a unique mode of proteasome bindingJiro Kikuchi, Naoya Shibayama, Satoshi Yamada, et al.
Pageof 5